Most Popular Articles : AIDS

Secondary Logo

Journal Logo

Most Popular Articles

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Gupta, Samir K.; Post, Frank A.; Arribas, José R.; More

AIDS. 33(9):1455-1465, July 15, 2019.

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition

Fonner, Virginia A.; Ridgeway, Kathleen; van der Straten, Ariane; More

AIDS. 37(6):957-966, May 1, 2023.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

May, Margaret T.; Gompels, Mark; Delpech, Valerie; More

AIDS. 28(8):1193-1202, May 15, 2014.

The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide

Friedland, Barbara A.; Gottert, Ann; Hows, Julian; More

AIDS. 34:S5-S18, September 1, 2020.

Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection

Cahn, Pedro; Sierra Madero, Juan; Arribas, José R.; More

AIDS. 36(1):39-48, January 1, 2022.

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment

Svensson Akusjärvi, Sara; Krishnan, Shuba; Ambikan, Anoop T.; More

AIDS. 37(7):1023-1033, June 1, 2023.

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; More

AIDS. 35(12):1957-1965, October 1, 2021.

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy

Mills, Anthony; Richmond, Gary J.; Newman, Cheryl; More

AIDS. 36(2):195-203, February 1, 2022.

HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

Suzuki, Kazuo; Levert, Angelique; Yeung, Julie; More

AIDS. 35(13):2095-2103, November 1, 2021.

Curable sexually transmitted infections among women with HIV in sub-Saharan Africa

Jarolimova, Jana; Platt, Laura R.; Curtis, Megan R.; More

AIDS. 36(5):697-709, April 1, 2022.

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

Sax, Paul E.; Andreatta, Kristen; Molina, Jean-Michel; More

AIDS. 36(11):1511-1520, September 01, 2022.

Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

De Francesco, Davide; Wit, Ferdinand W.; Bürkle, Alexander; More

AIDS. 33(2):259-268, February 1, 2019.

HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM

Gosens, Karien C.M.; van der Zee, Ramon P.; van Heukelom, Matthijs L. Siegenbeek; More

AIDS. 35(11):1753-1764, September 1, 2021.

Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy

Lachâtre, Marie; Pasquet, Armelle; Ajana, Faïza; More

AIDS. 36(8):1061-1071, July 1, 2022.

Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment

Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; More

AIDS. 36(2):185-194, February 1, 2022.

Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries

Geibel, Scott; Gottert, Ann; Friedland, Barbara A.; More

AIDS. 34:S33-S41, September 1, 2020.

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection

Peluso, Michael J.; Spinelli, Matthew A.; Deveau, Tyler-Marie; More

AIDS. 36(12):F7-F16, October 1, 2022.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

Laut, Kamilla Grønborg; Shepherd, Leah; Gottfredsson, Magnus; More

AIDS. 32(18):2807-2819, November 28, 2018.

High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy

Huik, Kristi; Hill, Shawn; George, Jomy; More

AIDS. 36(13):1835-1840, November 1, 2022.

High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa

Chachage, Mkunde; Parikh, Ajay P.; Mahenge, Anifrid; More

AIDS. 37(4):625-635, March 15, 2023.

COVID-19 vaccine immunogenicity in people with HIV

Costiniuk, Cecilia T.; Singer, Joel; Lee, Terry; More

AIDS. 37(1):F1-F10, January 1, 2023.

Differential patterns of postmigration HIV-1 infection acquisition among Portuguese immigrants of different geographical origins

Pimentel, Victor Figueiredo; Pingarilho, Marta; Sole, Giordano; More

AIDS. 36(7):997-1005, June 1, 2022.

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation

Falutz, Julian; Allas, Soraya; Mamputu, Jean-Claude; More

AIDS. 22(14):1719-1728, September 12, 2008.

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

Lapointe, Hope R.; Mwimanzi, Francis; Cheung, Peter K.; More

AIDS. 37(5):709-721, April 1, 2023.

Integration and scale-up of efforts to measure and reduce HIV-related stigma: the experience of Thailand

Siraprapasiri, Taweesap; Srithanaviboonchai, Kriengkrai; Chantcharas, Parichart; More

AIDS. 34:S103-S114, September 1, 2020.